Related Experiment Video
Updated: Feb 19, 2026
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Elucidating immunometabolic targets in glioblastoma
Pooja Agarwal1, Michael J Pajor1, David M Anson1
1Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at PeoriaPeoria, IL, USA.
Abstract:
Immunometabolism has recently emerged on the forefront of cancer research as a new avenue to potentially develop more effective and targeted treatment options. Several pathologically altered metabolic targets across various cancer types have been identified, including lactate in aerobic glycolysis; tryptophan in amino acid metabolism; and arginine in the urea cycle. Numerous advancements have improved our understanding of the dual function of these targets in influencing immune functions as an auxiliary function to their well-established metabolic role. This paper provides a comprehensive overview of immunometabolism research and attempts to provide insight into potential immunometabolic targets in glioblastoma for the purpose of future development and study of targeted therapies.
Insights
Immunometabolism research reveals how cancer cells alter metabolic pathways like glycolysis and amino acid metabolism to evade immune responses. Understanding these targets may lead to novel glioblastoma therapies.
Area of Science:
- Cancer research
- Immunology
- Metabolic pathways
Background:
- Immunometabolism is a rapidly advancing field in cancer research.
- Altered metabolic pathways (e.g., aerobic glycolysis, amino acid metabolism, urea cycle) are implicated in various cancers.
- Metabolic targets like lactate, tryptophan, and arginine have dual roles in metabolism and immune function.
Purpose of the Study:
- To provide a comprehensive overview of immunometabolism research.
- To identify potential immunometabolic targets in glioblastoma.
- To inform future targeted therapy development for glioblastoma.
Main Methods:
- Literature review of immunometabolism research.
- Analysis of metabolic alterations in cancer.
- Identification of key metabolic pathways and targets.
Main Results:
- Several critical metabolic targets have been identified across cancer types.
- The interplay between metabolism and immune function is increasingly understood.
- Specific metabolic pathways in glioblastoma show potential for therapeutic intervention.
Conclusions:
- Immunometabolism offers a promising avenue for developing targeted cancer therapies.
- Further research into glioblastoma immunometabolism is warranted.
- Targeting metabolic pathways could enhance treatment efficacy and overcome immune evasion.
More Related Videos
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
